about
Endotoxin-activated cultured neonatal rat cardiomyocytes express functional surface-associated interleukin-1alphaThe enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist.Carvedilol in the treatment of chronic heart failure.A glossary of circulating cytokines in chronic heart failure.Immune and neurohormonal pathways in chronic heart failure.Clinical trials update from the American Heart Association meeting: PROSPER, DIAL, home care monitoring trials, immune modulation therapy, COMPANION and anaemia in heart failure.Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.Biomarkers of heart failure with normal ejection fraction: a systematic review.Epigenetics, inflammation and metabolism in right heart failure associated with pulmonary hypertension.CA 125 levels and left ventricular function in patients with end-stage renal disease on maintenance hemodialysis.Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle.Biventricular versus right ventricular pacing decreases immune activation and augments nitric oxide production in patients with chronic heart failure.C-reactive protein level on admission and time to and cause of death in patients hospitalized for acute heart failure.Expression of programmed cell death-1 and its ligand B7 homolog 1 in peripheral blood lymphocytes from patients with peripartum cardiomyopathy.
P2860
Q28583222-0395F049-3772-4963-AD48-4C2B5B61E258Q30320708-7C57E16E-2BDF-496C-9FE2-90BA32C12319Q34241046-CE60ADAD-FDF1-480C-B9D1-AFF407BD12C0Q34398220-5B8E28E9-D729-4E3C-A457-161DEC636E9CQ34513186-088CB73B-2417-4BBD-914B-8A948BDAA4AFQ35057082-5BEEDB22-1599-4510-87CA-B113C5B2054AQ36817975-F0ED1423-01F7-46EA-922C-2A8832DE1BF7Q38120919-7348304F-32A2-4375-B287-CA000C7ACA8EQ39382663-19EA85F0-B642-4C1E-875E-7004691ADB8AQ44526003-E4C24320-4524-4BCA-B856-7CC1F11D41AFQ46634110-14689D51-FAFF-4236-8F4B-88F89F1CBB9AQ46932873-12D4E6DF-344B-44AA-B7A4-944E64510A16Q47777713-98B332FF-2784-4898-97DB-12C08B724B13Q48380777-D1E3088B-D1ED-4042-B671-376766436355
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
How are cytokines activated in heart failure?
@ast
How are cytokines activated in heart failure?
@en
type
label
How are cytokines activated in heart failure?
@ast
How are cytokines activated in heart failure?
@en
prefLabel
How are cytokines activated in heart failure?
@ast
How are cytokines activated in heart failure?
@en
P2860
P1476
How are cytokines activated in heart failure?
@en
P2093
P2860
P304
P356
10.1016/S1388-9842(99)00049-5
P577
1999-12-01T00:00:00Z